A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Healthy Chinese Adults and Patients With Chronic Spontaneous Urticaria.
Clinical trial NCT06864507 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06864507
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-31
- Primary completion
- 2026-09-27
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.